Tobacco Cessation Intervention

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical Trial Summary

This study is planned as an evaluation of a low cost, simple smoking cessation intervention. There is very little information about the effectiveness of a simple tobacco cessation strategy. Therefore, our objective is to obtain estimates of effectiveness that can be used to refine existing programs or to develop new ones.

See also
Status	Clinical Trial	Phase
Completed	`NCT00257088` - The Whole Day First Grade Program	Phase 4
Recruiting	`NCT05920772` - Process and Effect Evaluation of the KickAsh! Intervention	N/A
Completed	`NCT00608426` - Proactive Tobacco Treatment for Veterans	N/A

NCT number	NCT03657511
Study type	Interventional
Source	Barbara Ann Karmanos Cancer Institute
Contact
Status	Completed
Phase	N/A
Start date	October 22, 2018
Completion date	June 21, 2021

Tobacco Cessation Intervention

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms